Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
2
0
0
Pardes Biosciences, Inc. Share · US69945Q1058 · PRDS (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Pardes Biosciences, Inc.
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 22,67 %
Shares Float 14,06 M
Shares Outstanding 62,01 M
Company Profile for Pardes Biosciences, Inc. Share
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.
Company Data
Name Pardes Biosciences, Inc.
Company Pardes Biosciences, Inc.
Symbol PRDS
Website
https://www.pardesbio.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US69945Q1058
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Thomas G. Wiggans
Market Capitalization 135 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 2173 Salk Avenue, 92008 Carlsbad
IPO Date 2021-12-27
ID Changes
| Date | From | To |
|---|---|---|
| 27.12.2021 | FSII | PRDS |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | PRDS |
More Shares
Investors who hold Pardes Biosciences, Inc. also have the following shares in their portfolio:
